BURKHOLDERIA CEPACIA GROWTH IN PRESERVED PHARMACEUTICAL ANTIHISTAMINIC ORAL SUSPENSION

  • Mostafa Essam Eissa Microbiological Quality Control Section Head in HIKMA Pharma Pharmaceutical Company, Egypt

Abstract

A chemically-preserved oral antihistaminic suspension based on fexofenadine as an active pharmaceutical ingredient and preserved with aminobenzoic acid esters (parabens) was found contaminated with Burkholderia cepacia (B. cepacia). This finding was detected only after six months from manufacturing. The bacterial count increased from 10, after six months, to 1475 Colony Forming Unit (CFU)/ml after nine months. The organism constituted continually increasing the hazard to the users long after passing undetected to the market. The current finding highlighted the importance of both appropriate neutralization method of the preservatives in the preservative efficacy test and the sensitivity of the method of bioburden enumeration and detection.

 

Keywords: Antihistaminic suspension, Fexofenadine, Parabens, Burkholderia cepacia, Chemically-preserved

Downloads

Download data is not yet available.

References

1. Elder DP, Crowley PJ. Antimicrobial preservatives part two: choosing a preservative. Available from http://www. americanpharmaceuticalreview.com/Featured-Articles/ 38885-Antimicrobial Preservatives-Part-Two-Choosing-a-Preservative. [Last accessed on 11 Apr 2015].
2. Haag TE, Loncrini DF. Cosmetic and drug preservation: esters of para-hydroxybenzoic acid. Kabara JJ. editor. New York: Marcel-Dekker; 1984.
3. USP38-NF33, Chapter<61>. Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests. United States Pharmacopoeia 38/National Formulary 33, Baltimore, MD, USA; 2015.
4. ICH Q1A (R2) Guideline. Stability testing of new drug substances and products. International Conference on Harmonization (ICH); 2003.
5. Eissa, ME. studies of microbial resistance against some disinfectants: microbial distribution & biocidal resistance in pharmaceutical manufacturing facility. 1st ed. LAP Saarbrücken: Lambert Academic Publishing GmbH and Co. KG; 2014.
6. USP38-NF33, Chapter<62>. Microbiological Examination of Non-sterile Products: Tests for Specified Microorganisms. United States Pharmacopoeia 38/National Formulary 33, Baltimore, MD, USA; 2015.
7. Eissa ME, Nouby AS. Validation of spore-forming organisms recovery from peroxygen-based disinfectants. J Pharm Res Clin Practice 2014;4 Suppl 2:23-32.
8. USP38-NF33, Chapter<51>. Antimicrobial Effectiveness Testing. United States Pharmacopoeia 38/National Formulary 33, Baltimore, MD, USA; 2015.
9. USP38-NF33, Chapter<1112>. Application of Water Activity Determination To Nonsterile Pharmaceutical Products. United States Pharmacopoeia 38/National Formulary 33, Baltimore, MD, USA; 2015.
10. Clontz L. Microbial Limit and Bioburden Tests: Validation Approaches and Global Requirements. 2nd ed. USA: CRC Press: Taylor and Francis Group; 2008.
Statistics
352 Views | 1987 Downloads
How to Cite
Eissa, M. E. “BURKHOLDERIA CEPACIA GROWTH IN PRESERVED PHARMACEUTICAL ANTIHISTAMINIC ORAL SUSPENSION”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 1, Nov. 2015, pp. 464-6, https://innovareacademics.in/journals/index.php/ijpps/article/view/8862.
Section
Case Study(s)